Shots:
- FDA has cleared Deseyne, a daily disposable soft contact lens for presbyopia that uses patented Extended Depth of Focus technology
- Deseyne provides continuous near, intermediate, & distance vision through Cataltheia’s patented hyper-refractive central zone, showing a clinical advantage over multifocal lenses with minimal patient adaptation, strong comfort, & no adverse events reported in studies
- Made from Vifilcon C hydrogel & enhanced with natural co-polymers, hyaluronic acid, & tamarind seed polysaccharide, Deseyne supports all-day hydration, comfort, & visual stability
Ref: Businesswire | Image: Bruno Vision Care | Press Release
Related News: Bruno Vision Care’s Deseyne Contact Lens Secures the US FDA’s Approval for Dry Eye Disease
PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com
